노바렉스

194700KOSDAQ기타 식품 제조업

66.8 / 100

Reference Date: 2026-04-13

Financial Score30.0 / 40

News Sentiment18.8 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average but PBR raises overvaluation concerns. Rose 6.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

NovaLex, established in 2008, specializes in manufacturing and exporting health functional foods, producing products such as supercritical omega-3 and VitaPack programs. The company holds 47 of South Korea's largest individually certified raw materials and leads market trends through ODM/OEM business. It manages financial risks to maintain financial stability.

Number of Employees

505people

Average Salary

58.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

6.99Industry Average 13.536.5Point

Lower than industry avg (good)

PBR

1.03Industry Average 0.641.0Point

1.6x industry avg (risky)

ROE

15.15Industry Average 2.727.0Point

5.6x industry avg (excellent)

Debt Ratio

4.21Industry Average 11.916.5Point

Half of industry avg (excellent)

Trend 2023~20259.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲17.2% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲38.3% (2-year basis)

ROE Trend

3.5 / 4

Avg ROE 12.7% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 75

Positive
노바렉스, 오송 2공장 착공…"생산능력 1조원으로 확대 "
노바렉스는 오송 2공장 착공을 통해 생산능력을 1조원으로 확대하며 글로벌 시장 확대에 대응할 예정입니다.
Positive
웰니스에 살아난 건기식…ODM업체 실적 '훨훨'
건강기능식품 시장이 웰니스 트렌드에 힘입어 성장하고 있으며, 노바렉스 등 ODM 업체들의 실적도 호조를 보이고 있습니다.

Detailed Momentum

52-week position3.0Point

52w lower range (36%)

Current 13,970Won52-week high 22,00052-week low 9,430

1-month return4.0Point

1m +6.89% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral정기주주총회결과2026-03-27
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-27
Neutral대표이사변경2026-03-27
Neutral감사보고서제출2026-03-19
Neutral사업보고서 (2025.12)2026-03-19